(Bloomberg) -- Swedish Prime Minister Stefan Lofven defended his country’s controversial strategy to fight the pandemic. Tokyo joined Australia’s second-biggest state in posting record coronavirus
Quest Diagnostics (NYSE:DGX) had its price target boosted by investment analysts at Credit Suisse Group from $126.00 to $128.00 in a research note issued to investors on Tuesday, BenzingaRatingsTable
The challenge of quarantining at home while awaiting a test result only grows the longer the results take to come back.

Slow Covid-19 Data Call For a Smarter Approach

09:25pm, Wednesday, 15'th Jul 2020
(Bloomberg Opinion) -- Covid-19 has been devilishly difficult to monitor, and therefore to control, in part because of the degree to which data lag reality. This happens because each link in the chain
As the NBA restarts in the Orlando bubble, Covid-19 testing is frequent and results come quickly. The league has been criticized for taking away resources and supplies, but it says it's increasing res
"The time is now," Dr. Robert Redfield, Director of the CDC, said Tuesday. "I think if we could get everybody to wear a mask right now I think in four, six, eight weeks we could bring this epidemic un
SECAUCUS, N.J., July 15, 2020 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has been named to the 2020 Disability Equality Index (D
Campus Health Project to Speak at LEAD1 Association’s COVID-19 Testing Webinar
Trump said that while coronavirus testing "is a good thing," it has also served as "fodder for the fake news to report cases."
The U.S. surpassed more than 60,000 new coronavirus cases, based on a seven-day moving average, for the first time on Monday, according to a CNBC analysis of data compiled by Johns Hopkins University.
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F
DGX vs. USPH: Which Stock Is the Better Value Option?
Quest Diagnostics Inc (NYSE: DGX) preannounced its second-quarter revenue at around $1.83 billion on Monday, beating Street estimates by about 18%. Preliminary also came in ahead, in the range of $1.

How Does Quest Diagnostics' Debt Look Like?

02:26pm, Tuesday, 14'th Jul 2020
Over the past three months, shares of Quest Diagnostics Inc. (NYSE: DGX) rose by 25.93%. Before we understand the importance of debt, let's look at how much debt Quest Diagnostics has.Quest Diagnostic
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE